Novartis to Help Fund Development of Gen-Probe MDx Platform | GenomeWeb

NEW YORK (GenomeWeb News) – As part of an expanded agreement between the firms, drug maker Novartis has agreed to help fund development of Gen-Probe's new automated molecular testing platform, Panther, for the blood screening market.

The partners have collaborated since 1998 on nucleic acid tests and instruments for the blood screening market. Under the expanded pact announced today, the firms intend to continue collaborating until the year 2025, and they expect to collaborate on the development of pharmacogenomic tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.